MSB11022 in Moderate to Severe Chronic Plaque Psoriasis
Public ClinicalTrials.gov record NCT02660580. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind Trial to Evaluate the Efficacy, Safety and Immunogenicity of MSB11022 Compared With Humira® in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Study identification
- NCT ID
- NCT02660580
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Fresenius Kabi SwissBioSim GmbH
- Industry
- Enrollment
- 443 participants
Conditions and interventions
Interventions
- Humira® Drug
- MSB11022 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 15, 2016
- Primary completion
- Dec 30, 2016
- Completion
- Dec 17, 2017
- Last update posted
- Dec 26, 2023
2016 – 2017
United States locations
- U.S. sites
- 6
- U.S. states
- 3
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| San Luis Dermatology & Laser Clinic, Inc. | San Luis Obispo | California | 93405 | — |
| Florida Academic Centers Research and Education | Coral Gables | Florida | 33134 | — |
| Palm Beach Research Center | West Palm Beach | Florida | 33409 | — |
| Dermatology Treatment and Research Center | Dallas | Texas | 75230 | — |
| Modern Research Associates | Dallas | Texas | 75231-5945 | — |
| Dermatology Clinical Research Center of San Antonio | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02660580, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 26, 2023 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02660580 live on ClinicalTrials.gov.